H S Javitz

Summary

Affiliation: SRI International
Country: USA

Publications

  1. ncbi Comparative dynamics of four smoking withdrawal symptom scales
    Harold S Javitz
    Center for Health Sciences, SRI International, 333 Ravenswood Avenue, Menlo Park, CA 94025, USA
    Addiction 107:1501-11. 2012
  2. ncbi Value of antimicrobials in the prevention and treatment of tuberculosis in the United States
    H S Javitz
    SRI International, Center for Health Sciences, Menlo Park, California 94025, USA
    Int J Tuberc Lung Dis 6:275-88. 2002
  3. ncbi The dynamics of the urge-to-smoke following smoking cessation via pharmacotherapy
    Harold S Javitz
    SRI International, Menlo Park, CA 94025, USA
    Addiction 106:1835-45. 2011
  4. ncbi Association of tobacco dependence and quit attempt duration with Rasch-modeled withdrawal sensitivity using retrospective measures
    Harold S Javitz
    Center for Health Sciences, SRI International, Menlo Park, CA 94025, USA
    Addiction 104:1027-35. 2009
  5. ncbi Cost-effectiveness of different combinations of bupropion SR dose and behavioral treatment for smoking cessation: a societal perspective
    Harold S Javitz
    Center for Health Sciences, SRI International, Menlo Park, Calif 94025, USA
    Am J Manag Care 10:217-26. 2004
  6. ncbi Return on investment of different combinations of bupropion SR dose and behavioral treatment for smoking cessation in a health care setting: an employer's perspective
    Harold S Javitz
    Center for Health Sciences, SRI International, Menlo Park, CA 94025, USA
    Value Health 7:535-43. 2004
  7. ncbi Financial burden of tobacco use: an employer's perspective
    Harold S Javitz
    Center for Health Sciences, SRI International, 333 Ravenswood Avenue, Menlo Park, CA 94025, USA
    Clin Occup Environ Med 5:9-29, vii. 2006
  8. ncbi In vitro investigation of host resistance to Toxoplasma gondii infection in microglia of BALB/c and CBA/Ca mice
    Y R Freund
    Immunology Program, Pharmaceutical Discovery Division, SRI International, Menlo Park, California 94025, USA
    Infect Immun 69:765-72. 2001
  9. ncbi Varenicline for smoking cessation: nausea severity and variation in nicotinic receptor genes
    G E Swan
    SRI International, Menlo Park, CA 94025, USA
    Pharmacogenomics J 12:349-58. 2012
  10. ncbi Predictors of 12-month outcome in smokers who received bupropion sustained-release for smoking cessation
    Gary E Swan
    Center for Health Sciences, SRI International, Menlo Park, California, USA
    CNS Drugs 22:239-56. 2008

Detail Information

Publications16

  1. ncbi Comparative dynamics of four smoking withdrawal symptom scales
    Harold S Javitz
    Center for Health Sciences, SRI International, 333 Ravenswood Avenue, Menlo Park, CA 94025, USA
    Addiction 107:1501-11. 2012
    ....
  2. ncbi Value of antimicrobials in the prevention and treatment of tuberculosis in the United States
    H S Javitz
    SRI International, Center for Health Sciences, Menlo Park, California 94025, USA
    Int J Tuberc Lung Dis 6:275-88. 2002
    ..To estimate the economic value of antimicrobials for the prevention and treatment of tuberculosis in the United States from 1954 through 1997...
  3. ncbi The dynamics of the urge-to-smoke following smoking cessation via pharmacotherapy
    Harold S Javitz
    SRI International, Menlo Park, CA 94025, USA
    Addiction 106:1835-45. 2011
    ..To examine person-specific urge-to-smoke trajectories during the first 7 days of abstinence and the relationship of trajectory parameters to continuous abstinence, demographics, medication and smoking history...
  4. ncbi Association of tobacco dependence and quit attempt duration with Rasch-modeled withdrawal sensitivity using retrospective measures
    Harold S Javitz
    Center for Health Sciences, SRI International, Menlo Park, CA 94025, USA
    Addiction 104:1027-35. 2009
    ..To examine whether Rasch modeling would yield a unidimensional withdrawal sensitivity measure correlating with factors associated with successful smoking cessation...
  5. ncbi Cost-effectiveness of different combinations of bupropion SR dose and behavioral treatment for smoking cessation: a societal perspective
    Harold S Javitz
    Center for Health Sciences, SRI International, Menlo Park, Calif 94025, USA
    Am J Manag Care 10:217-26. 2004
    ....
  6. ncbi Return on investment of different combinations of bupropion SR dose and behavioral treatment for smoking cessation in a health care setting: an employer's perspective
    Harold S Javitz
    Center for Health Sciences, SRI International, Menlo Park, CA 94025, USA
    Value Health 7:535-43. 2004
    ....
  7. ncbi Financial burden of tobacco use: an employer's perspective
    Harold S Javitz
    Center for Health Sciences, SRI International, 333 Ravenswood Avenue, Menlo Park, CA 94025, USA
    Clin Occup Environ Med 5:9-29, vii. 2006
    ....
  8. ncbi In vitro investigation of host resistance to Toxoplasma gondii infection in microglia of BALB/c and CBA/Ca mice
    Y R Freund
    Immunology Program, Pharmaceutical Discovery Division, SRI International, Menlo Park, California 94025, USA
    Infect Immun 69:765-72. 2001
    ..gondii replication after in vitro stimulation with IFN-gamma plus TNF-alpha or with LPS. Differences in NO production but not in IFN-gamma-dependent inhibition of T. gondii replication were observed between CBA/Ca and BALB/c microglia...
  9. ncbi Varenicline for smoking cessation: nausea severity and variation in nicotinic receptor genes
    G E Swan
    SRI International, Menlo Park, CA 94025, USA
    Pharmacogenomics J 12:349-58. 2012
    ..As nausea is the most common reason for discontinuance of varenicline, further pharmacogenetic investigations are warranted...
  10. ncbi Predictors of 12-month outcome in smokers who received bupropion sustained-release for smoking cessation
    Gary E Swan
    Center for Health Sciences, SRI International, Menlo Park, California, USA
    CNS Drugs 22:239-56. 2008
    ..To examine heterogeneity in outcome at 12 months following 8 weeks of treatment for smoking cessation with bupropion sustained-release (SR) 150 or 300 mg/day combined with behavioural counselling...
  11. ncbi Telephone-based tobacco-cessation treatment: re-enrollment among diverse groups
    Beatriz H Carlini
    Free and Clear, Inc, Seattle, Washington 98104, USA
    Am J Prev Med 35:73-6. 2008
    ..This study aimed to determine the rates of quitline re-enrollment and to compare the responses of people of varying racial/ethnic identities to invitations utilizing different communication strategies...
  12. ncbi Heterogeneity in 12-month outcome among female and male smokers
    Gary E Swan
    Center for Health Sciences, SRI International, Menlo Park, CA 94025, USA
    Addiction 99:237-50. 2004
    ..To examine heterogeneity in outcome following treatment for smoking cessation with combined bupropion SR and behavioral counseling in women and men...
  13. ncbi Reliability of adult retrospective recall of lifetime tobacco use
    Janet Brigham
    SRI International, Menlo Park, CA 94043, USA
    Nicotine Tob Res 10:287-99. 2008
    ..Few differences in the reliability of recall were apparent between sexes and between age groups. These results indicate that recall of important tobacco use information can form a reliable basis for research...
  14. ncbi Cost of illness of chronic angina
    Harold S Javitz
    Center for Health Sciences, SRI International, Menlo Park, California, USA
    Am J Manag Care 10:S358-69. 2004
    ..Some components of care were not available, and estimated costs will be significantly higher if private payer reimbursement rates are used...
  15. ncbi Adolescent smoking trajectories and nicotine dependence
    Christina N Lessov-Schlaggar
    Washington University, St Louis, MO 63110, USA
    Nicotine Tob Res 10:341-51. 2008
    ....
  16. ncbi The direct cost of care for psoriasis and psoriatic arthritis in the United States
    Harold S Javitz
    Center for Health Sciences, SRI International, Menlo Park, California 94025, USA
    J Am Acad Dermatol 46:850-60. 2002
    ....